These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 27516169)

  • 1. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
    Rines AK; Sharabi K; Tavares CD; Puigserver P
    Nat Rev Drug Discov; 2016 Nov; 15(11):786-804. PubMed ID: 27516169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of hepatic glucose production as a therapeutic target in the treatment of diabetes.
    Wu C; Okar DA; Kang J; Lange AJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):51-9. PubMed ID: 15777204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole grains-derived functional ingredients against hyperglycemia: targeting hepatic glucose metabolism.
    Wang Y; Fan M; Qian H; Ying H; Li Y; Wang L
    Crit Rev Food Sci Nutr; 2024; 64(20):7268-7289. PubMed ID: 36847153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Effects of Metformin in Humans.
    Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
    Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intervention of hepatic glucose production. Small molecule regulators of potential targets for Type 2 diabetes therapy.
    Barf T
    Mini Rev Med Chem; 2004 Oct; 4(8):897-908. PubMed ID: 15544551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the CNS to treat type 2 diabetes.
    Sandoval DA; Obici S; Seeley RJ
    Nat Rev Drug Discov; 2009 May; 8(5):386-98. PubMed ID: 19404312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy.
    McCormack JG; Westergaard N; Kristiansen M; Brand CL; Lau J
    Curr Pharm Des; 2001 Sep; 7(14):1451-74. PubMed ID: 11529255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic action of borapetoside A from the plant Tinospora crispa in mice.
    Ruan CT; Lam SH; Lee SS; Su MJ
    Phytomedicine; 2013 Jun; 20(8-9):667-75. PubMed ID: 23523259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and its liver targets in the treatment of type 2 diabetes.
    Radziuk J; Bailey CJ; Wiernsperger NF; Yudkin JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Jun; 3(2):151-69. PubMed ID: 12769787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
    Bagger JI; Knop FK; Holst JJ; Vilsbøll T
    Diabetes Obes Metab; 2011 Nov; 13(11):965-71. PubMed ID: 21615669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic glucose production: therapeutic target in type 2 diabetes?
    Staehr P; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Obes Metab; 2002 Jul; 4(4):215-23. PubMed ID: 12099970
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of metformin on hepatic glucose production in Japanese patients with type 2 diabetes mellitus.
    Takahara M; Kaneto H; Katakami N; Matsuhisa M; Shimomura I
    Endocr J; 2012; 59(9):845-7. PubMed ID: 22673502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin regulation of gluconeogenesis.
    Hatting M; Tavares CDJ; Sharabi K; Rines AK; Puigserver P
    Ann N Y Acad Sci; 2018 Jan; 1411(1):21-35. PubMed ID: 28868790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Bioactive Phytoconstituents as Modulators of Hepatic Carbohydrates Metabolising Enzymes: A Target Specific Approach to Treat Diabetes Mellitus.
    Sharma S; Choudhary M; Budhwar V
    Curr Diabetes Rev; 2022; 18(9):e100222201016. PubMed ID: 35142270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New hepatic targets for glycaemic control in diabetes.
    Agius L
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):587-605. PubMed ID: 18054737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-lowering Strategies in Diabetes: Pharmacological Development of New Antidiabetic Drugs.
    Schwartsburd P
    Curr Pharm Des; 2018; 24(9):1007-1011. PubMed ID: 29283045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice.
    Yan F; Li N; Shi J; Li H; Yue Y; Jiao W; Wang N; Song Y; Huo G; Li B
    Food Funct; 2019 Sep; 10(9):5804-5815. PubMed ID: 31461095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney in diabetes: from organ damage target to therapeutic target.
    Salvatore T; Carbonara O; Cozzolino D; Torella R; Nasti R; Lascar N; Sasso FC
    Curr Drug Metab; 2011 Sep; 12(7):658-66. PubMed ID: 21495978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent and emerging anti-diabetic molecular targets.
    Almasi F; Mohammadipanah F
    J Drug Target; 2021 Jun; 29(5):491-506. PubMed ID: 33336602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.